267 related articles for article (PubMed ID: 20671643)
1. The role of stent-grafts for prevention and treatment of restenosis.
Kwa AT; Yeo KK; Laird JR
J Cardiovasc Surg (Torino); 2010 Aug; 51(4):579-89. PubMed ID: 20671643
[TBL] [Abstract][Full Text] [Related]
2. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM;
J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
[TBL] [Abstract][Full Text] [Related]
3. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Pearl G; Theune B; Black S
J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Hohman S; Pearl G; Theune B
J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
[TBL] [Abstract][Full Text] [Related]
6. The role of superficial femoral artery endoluminal bypass in long de novo lesions and in-stent restenosis.
Doomernik DE; Golchehr B; Lensvelt MM; Reijnen MM
J Cardiovasc Surg (Torino); 2012 Aug; 53(4):447-57. PubMed ID: 22854524
[TBL] [Abstract][Full Text] [Related]
7. Role of total endoluminal superficial femoral artery bypass.
Gable D
J Cardiovasc Surg (Torino); 2011 Oct; 52(5):683-700. PubMed ID: 21799474
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease.
Kedora J; Hohmann S; Garrett W; Munschaur C; Theune B; Gable D
J Vasc Surg; 2007 Jan; 45(1):10-6; discussion 16. PubMed ID: 17126520
[TBL] [Abstract][Full Text] [Related]
9. Evolving modalities for femoropopliteal interventions.
Ansel GM; Lumsden AB
J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II82-97. PubMed ID: 19624076
[TBL] [Abstract][Full Text] [Related]
10. New stents for SFA.
MINAR E; SCHILLINGER M
J Cardiovasc Surg (Torino); 2009 Oct; 50(5):635-45. PubMed ID: 19741579
[TBL] [Abstract][Full Text] [Related]
11. Management of flush superficial femoral artery occlusions with combined open femoral endarterectomy and endovascular femoral-popliteal angioplasty and stent-grafting.
Hayes DJ; Dougherty MJ; Calligaro KD
Ann Vasc Surg; 2011 May; 25(4):559.e19-23. PubMed ID: 21549939
[TBL] [Abstract][Full Text] [Related]
12. Modification of the Viabahn Padova sutureless technique for challenging anastomosis between a prosthetic graft and a circumferentially calcified target artery.
Piazza M; Bonvini S; Ferretto L; Menegolo M; Frigatti P; Ricotta JJ; Grego F
J Endovasc Ther; 2012 Jun; 19(3):457-60. PubMed ID: 22788901
[TBL] [Abstract][Full Text] [Related]
13. How should we manage thrombosis of Viabahn stent-graft? A case report focused on catheter-directed thrombolysis.
Kang WY; Campia U; Bernardo NL; Didier RJ; Negi SI; Kiramijyan S; Koifman E; Baker NC; Lipinski MJ; Escarcega RO; Torguson R; Waksman R
Cardiovasc Revasc Med; 2016 Mar; 17(2):134-7. PubMed ID: 26994746
[TBL] [Abstract][Full Text] [Related]
14. Stent-grafts are the best way to treat complex in-stent restenosis lesions in the superficial femoral artery: 24-month results from a multicenter randomized trial.
Bosiers M; Deloose K; Callaert J; Verbist J; Hendriks J; Lauwers P; Schroë H; Lansink W; Scheinert D; Schmidt A; Zeller T; Beschorner U; Noory E; Torsello G; Austermann M; Wauters J
J Cardiovasc Surg (Torino); 2020 Oct; 61(5):617-625. PubMed ID: 33231029
[TBL] [Abstract][Full Text] [Related]
15. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U
J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
[TBL] [Abstract][Full Text] [Related]
16. Viabahn for femoropopliteal in-stent restenosis.
Al Shammeri O; Bitar F; Ghitelman J; Soukas PA
Ann Saudi Med; 2012; 32(6):572-82. PubMed ID: 23396019
[TBL] [Abstract][Full Text] [Related]
17. Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease.
Schneider JR; Verta MJ; Alonzo MJ; Hahn D; Patel NH; Kim S
Vasc Endovascular Surg; 2011 Jul; 45(5):391-7. PubMed ID: 21669863
[TBL] [Abstract][Full Text] [Related]
18. Ten years' experience in endovascular repair of popliteal artery aneurysm using the Viabahn endoprosthesis: a report from two Italian vascular centers.
Speziale F; Sirignano P; Menna D; Capoccia L; Mansour W; Serrao E; Ronchey S; Alberti V; Esposito A; Mangialardi N
Ann Vasc Surg; 2015 Jul; 29(5):941-9. PubMed ID: 25757986
[TBL] [Abstract][Full Text] [Related]
19. Duplex ultrasound diagnosis of failing stent grafts placed for occlusive disease.
Troutman DA; Madden NJ; Dougherty MJ; Calligaro KD
J Vasc Surg; 2014 Dec; 60(6):1580-4. PubMed ID: 25256612
[TBL] [Abstract][Full Text] [Related]
20. Stent-Graft Length Is Associated with Decreased Patency in Treatment of Central Venous Stenosis in Hemodialysis Patients.
Boutrous ML; Alvarez AC; Okoye OT; Laws JC; Jacobs DL; Smeds MR
Ann Vasc Surg; 2019 Aug; 59():225-230. PubMed ID: 31009722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
